Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD? - PACE-CME

Aspirin or PYi monotherapy for secondary prevention in patients with CAD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Effects of a guideline-based approach on achieving LDL-c goals
Effects of a guideline-based approach on achieving LDL-c goals
ESC 2022
Effects of a guideline-based approach on achieving LDL-c goals
- Aaram Omar Khader, MD
CODE-EHR, a framework for the use of EHR data in clinical research
CODE-EHR, a framework for the use of EHR data in clinical research
ESC 2022
CODE-EHR, a framework for the use of EHR data in clinical research
- Prof. Folkert Asselbergs, MD, PhD
Autoimmune diseases and risk of CVD
Autoimmune diseases and risk of CVD
ESC 2022
Autoimmune diseases and risk of CVD
- Prof. Naveed Sattar
Meta-analysis on effects of statins on muscle symptoms
Meta-analysis on effects of statins on muscle symptoms
ESC 2022
Meta-analysis on effects of statins on muscle symptoms
- Prof. Colin Baigent